Ludhiana: A day after the Punjab govt approved its controversial land pooling policy, the Shiromani Akali Dal (SAD) announced it will intensify its opposition by launching village-level affidavit ...

The Recluse can cast 14 individual spells based on how she collects affinity residues as part of her Magic Cocktail combo. The Recluse is one of the more difficult to learn Nightfarers thanks to ...

The Punjab cabinet on Monday approved the introduction of a new land pooling policy in the State, even as the Shiromani Akali Dal (SAD) criticised the move, terming it anti-farmer. The decision ...

The Washington-based wholesale club recently announced it's bringing back the combo pizza. Only this time, the food offering is in a slightly different form. Priced at $6.99, the "Combo Calzone ...

St. Anne Catholic High School students Michael Bourdeau (Gr. 12 - piano), Luiz Correa (Gr. 11 - trumpet), Julien Lewis (Gr. 12 - upright bass), Andrew Matchett (Gr. 12 - drums), Matthew Verzosa ...

The MATTERHORN trial showed improved EFS and OS with durvalumab plus chemotherapy in gastric/GEJ cancer patients compared to chemotherapy alone. Durvalumab treatment resulted in a higher pCR rate ...

Please provide your email address to receive an email when new articles are posted on . Survival outcomes with the sacituzumab govitecan combination outweighed outcomes with chemotherapy ...

Opposition parties, including the Shiromani Akali Dal (SAD) and Congress, have slammed the move, calling it a “land grab in disguise” and questioning the timing of the decision when farmers ...

Night Moves explores going out through the lens of beauty. Here, discover how your favorite stars get ready to paint the town red, including what music they're playing to set the mood, the ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial.

GSK's latecomer to the PD-1/PD-L1 inhibitor category Jemperli has barely started to bring in revenues, and is a world away from the company's hopes of blockbuster revenues by 2031. The drugmaker ...